Corticosteroids are the major contributors to the risk for serious infections in autoimmune disorders with severe renal involvement-Reference-Cited by-同舟云学术

Corticosteroids are the major contributors to the risk for serious infections in autoimmune disorders with severe renal involvement

Published:2021-02-17 Issue:8 Volume:40 Page:3285-3297
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Obrișcă Bogdan^ORCID,Vornicu Alexandra,Jurubiță Roxana,Achim Camelia,Bobeică Raluca,Andronesi Andreea,Sorohan Bogdan,Herlea Vlad,Procop Alexandru,Dina Constantin,Ismail Gener

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s10067-021-05646-2.pdf

Reference36 articles.

1. Parikh SV, Rovin BH (2016) Current and emerging therapies for lupus nephritis. J Am Soc Nephrol 27(10):2929–2939

2. Kitching AR, Anders HJ, Basu N, Brouwer E, Gordon J, Jayne DR, Kullman J, Lyons PA, Merkel PA, Savage COS, Specks U, Kain R (2020) ANCA-associated vasculitis. Nat Rev Dis Prim 6:71

3. Little MA, Nightingale P, Verburgh CA, Hauser T, De Groot K, Savage C et al (2010) Early mortality in systemic vasculitis : relative contribution of adverse events and active vasculitis. Ann Rheum Dis 69:1036–1043

4. Austin HA, Klippel JH, Balow JE, Riche NGH, Steinberg AD, Plotz PH et al (1986) Therapy of lupus nephritis: controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314:614–619

5. Boumpas DT, Austin HA, Vaugn EM, Klippel JH, Steinberg AD, Yarboro CH et al (1992) Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 340:741–745

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoimmunity and clinical pathology amelioration in SLE by Dexamethasone primed Mesenchymal Stem Cell derived conditioned media;2024-07-02

2. Serum ceramide levels in systemic lupus erythematosus patients: A novel biomarker for renal impairment;Journal of The Egyptian Society of Nephrology and Transplantation;2024-07

3. Systematic Literature Review on the Incidence of Herpes Zoster in Populations at Increased Risk of Disease in the EU/EEA, Switzerland, and the UK;Infectious Diseases and Therapy;2024-04-24

4. Treatment of membranous nephropathy: Perspectives on current and future therapies;Frontiers in Nephrology;2023-01-27

5. Characteristics of SARS-CoV-2 Infection in an Actively Monitored Cohort of Patients with Lupus Nephritis;Biomedicines;2022-09-28